198 related articles for article (PubMed ID: 17562781)
1. Do statins lower blood pressure?
Mangat S; Agarwal S; Rosendorff C
J Cardiovasc Pharmacol Ther; 2007 Jun; 12(2):112-23. PubMed ID: 17562781
[TBL] [Abstract][Full Text] [Related]
2. Early vascular benefits of statin therapy.
Tsiara S; Elisaf M; Mikhailidis DP
Curr Med Res Opin; 2003; 19(6):540-56. PubMed ID: 14594527
[TBL] [Abstract][Full Text] [Related]
3. [Do the pleiotropic effects of statins have a clinical significance?].
Vergès B
Arch Mal Coeur Vaiss; 2004 Dec; 97(12):1231-5. PubMed ID: 15669365
[TBL] [Abstract][Full Text] [Related]
4. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
Robinson JG
Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
[TBL] [Abstract][Full Text] [Related]
5. Statins in hypertension: are they a new class of antihypertensive agents?
Feldstein CA
Am J Ther; 2010; 17(3):255-62. PubMed ID: 19918164
[TBL] [Abstract][Full Text] [Related]
6. Emerging non-statin LDL-lowering therapies for dyslipidemia and atherosclerosis.
Shah PK
Rev Cardiovasc Med; 2003; 4(3):136-41. PubMed ID: 12949442
[TBL] [Abstract][Full Text] [Related]
7. Statins: another class of antihypertensive agents?
Milionis HJ; Liberopoulos EN; Achimastos A; Elisaf MS; Mikhailidis DP
J Hum Hypertens; 2006 May; 20(5):320-35. PubMed ID: 16511505
[TBL] [Abstract][Full Text] [Related]
8. [Statins: possibly more than just lowering of the lipid level].
Visseren FL; Lansberg PJ; Erkelens DW; Kastelein JJ
Ned Tijdschr Geneeskd; 2000 Feb; 144(7):316-21. PubMed ID: 10707742
[TBL] [Abstract][Full Text] [Related]
9. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
Hausenloy DJ; Yellon DM
Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
[TBL] [Abstract][Full Text] [Related]
10. Beneficial cardiovascular pleiotropic effects of statins.
Davignon J
Circulation; 2004 Jun; 109(23 Suppl 1):III39-43. PubMed ID: 15198965
[TBL] [Abstract][Full Text] [Related]
11. Does the blood pressure-lowering effect of statins contribute to their beneficial cardiovascular effects?
Correa V; Gus M; Fuchs FD
Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):775-9. PubMed ID: 20528635
[TBL] [Abstract][Full Text] [Related]
12. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.
Pearson TA; Ballantyne CM; Veltri E; Shah A; Bird S; Lin J; Rosenberg E; Tershakovec AM
Am J Cardiol; 2009 Feb; 103(3):369-74. PubMed ID: 19166691
[TBL] [Abstract][Full Text] [Related]
13. Statins and hypertension.
Pelat M; Balligand JL
Semin Vasc Med; 2004 Nov; 4(4):367-75. PubMed ID: 15861317
[TBL] [Abstract][Full Text] [Related]
14. [Pleiotropic effects of statins].
Westerweel PE; Verhaar MC; Rabelink TJ
Ned Tijdschr Geneeskd; 2004 Jul; 148(29):1431-5. PubMed ID: 15326645
[TBL] [Abstract][Full Text] [Related]
15. Impact of statin therapy on central aortic pressures and hemodynamics: principal results of the Conduit Artery Function Evaluation-Lipid-Lowering Arm (CAFE-LLA) Study.
Williams B; Lacy PS; Cruickshank JK; Collier D; Hughes AD; Stanton A; Thom S; Thurston H;
Circulation; 2009 Jan; 119(1):53-61. PubMed ID: 19103995
[TBL] [Abstract][Full Text] [Related]
16. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
[TBL] [Abstract][Full Text] [Related]
17. Antioxidative effects of statins.
Adam O; Laufs U
Arch Toxicol; 2008 Dec; 82(12):885-92. PubMed ID: 18670762
[TBL] [Abstract][Full Text] [Related]
18. Statins in heart failure. Beyond the lipid lowering effect.
Tousoulis D; Charakida M; Stefanadi E; Siasos G; Latsios G; Stefanadis C
Int J Cardiol; 2007 Feb; 115(2):144-50. PubMed ID: 17175040
[TBL] [Abstract][Full Text] [Related]
19. [Vasoprotective effects of statins and angiotensin II blockers in atherothrombosis].
Egido J; Ruiz-Ortega M; Muñoz-García B; Martín-Ventura JL; Blanco-Colio LM
Nefrologia; 2005; 25 Suppl 2():117-28. PubMed ID: 16050414
[TBL] [Abstract][Full Text] [Related]
20. [What other effects do statins have except their effect on lipids?].
Tikkanen MJ
Duodecim; 1998; 114(13):1299-301. PubMed ID: 11552256
[No Abstract] [Full Text] [Related]
[Next] [New Search]
